EVOK icon

Evoke Pharma
EVOK

Overview Fund Trends Analyst Outlook Journalist POV

11 hedge funds and large institutions have $995K invested in Evoke Pharma in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

71% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 7

Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$55.5K
2
+$919
3
+$90
4
Citigroup
Citigroup
New York
+$20

Top Sellers

1
-$366K
2
-$26.3K
3
-$15.8K
4
Citadel Advisors
Citadel Advisors
Florida
-$6.3K
5
State Street
State Street
Massachusetts
-$5.64K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$339K
2
$327K
3
$268K
4
$55.5K
5
$3.88K
6
$581
7
$428
8
$148
9
$119
10
$81
11
$20
12
–
13
–
14
–
15
–
16
–
17
–